Información:
Error:
ID
42142
Descripción
A Study of ARQ 197 in Combination With Erlotinib; ODM derived from: https://clinicaltrials.gov/show/NCT01251796
Link
https://clinicaltrials.gov/show/NCT01251796
Palabras clave
Versiones (2)
- 29/5/16 29/5/16 -
- 13/4/21 13/4/21 - Dr. rer. medic Philipp Neuhaus
Subido en
13 de abril de 2021
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796
Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796
- StudyEvent: Eligibility
Similar models
Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
informed consent
Item
voluntary written informed consent for study participation must be obtained
boolean
C0021430 (UMLS CUI [1])
non-small-cell lung cancer
Item
a histologically or cytologically confirmed advanced/recurrent non-small-cell lung cancer
boolean
C0007131 (UMLS CUI [1])
chemotherapy regimen
Item
history of ≥1 prior chemotherapy regimen (treatment with egfr tyrosine kinase inhibitors will be counted as one regimen)
boolean
C0392920 (UMLS CUI [1,1])
C1443775 (UMLS CUI [1,2])
C1443775 (UMLS CUI [1,2])
ecog
Item
ecog ps of 0 or 1
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
life expectancy of ≥3 months
boolean
C0023671 (UMLS CUI [1])
CYP2 gene
Item
poor metabolizers as defined by cyp2c19 genotype
boolean
C1332828 (UMLS CUI [1])
egfr-tki
Item
anti-cancer chemotherapy, anti-cancer therapy with egfr-tki, hormone therapy, radiotherapy, immunotherapy, other investigational agents or anti-cancer antibody therapy within 28 days prior to arq 197 dose
boolean
cancer surgery
Item
surgery for cancer within 28 days prior to arq 197 dose
boolean
C0920424 (UMLS CUI [1])
Multiple malignancy
Item
active double cancer
boolean
C0346429 (UMLS CUI [1])
brain metastases
Item
known symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1])
intercurrent illness
Item
an intercurrent illness that is uncontrolled (e.g., infection, symptomatic congestive heart failure, unstable angina pectoris, symptomatic arrhythmia, interstitial pneumonia)
boolean
C3640977 (UMLS CUI [1])
pregnant or lactating
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
contraceptive measures
Item
subjects who wish to have a child and who would not agree to use contraceptive measures
boolean
C0700589 (UMLS CUI [1])
Sin comentarios